Skip to main content
Login
Contact
Subscribe
Search form
Search
The Borger News-Herald
Home
Forms
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Calendar
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Epizyme Inc
(NQ:
EPZM
)
8.095
USD
-0.135 (-1.64%)
Official Closing Price
Updated: 6:18 PM EDT, Apr 16, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Epizyme Inc
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
Interesting EPZM Put And Call Options For June 18th
April 16, 2021
Investors in Epizyme Inc. (EPZM) saw new options become available today, for the June 18th expiration..
Tags
Stocks
From
Market News Video
Analysts See 12% Upside For The Holdings of JKK
April 16, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 06, 2021
Gainers Cara Therapeutics (NASDAQ:CARA) shares rose 11.88% to $26.65 during Tuesday's pre-market session. The ...
Tags
MTP
Top Gainers
APTX
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2021
March 31, 2021
Upgrades Barclays upgraded the previous rating for Textron Inc (NYSE:TXT) from Equal-Weight to Overweight. In the fourth ...
Tags
XYL
BHP
KMX
From
Benzinga
The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings
March 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ORPH
RHHBY
Benzinga
From
Benzinga
The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs
March 26, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
Penny Stocks
GNMK
RXDX
From
Benzinga
The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut
March 25, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
NLTX
UPC
DBTX
From
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 24, 2021
Before 10 a.m. ET on Wednesday, 26 companies set new 52-week lows. Intriguing Points: The company with the ...
Tags
CNCE
Benzinga
AFIB
From
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 23, 2021
Tuesday morning saw 16 companies set new 52-week lows. Things to Consider: The largest company by market ...
Tags
EPZM
Market News
52 Week Lows
From
Benzinga
First Week of EPZM November 19th Options Trading
March 19, 2021
Investors in Epizyme Inc. (EPZM) saw new options become available this week, for the November 19th expiration..
Tags
Stocks
From
Market News Video
28 Stocks Moving in Tuesday's Pre-Market Session
March 16, 2021
Gainers SunLink Health Systems, Inc. (NYSE: SSY) shares rose 82.4% to $3.52 in pre-market trading as the company reported $2 ...
Tags
YTRA
News
CHNR
From
Benzinga
Analysts Anticipate XBI Will Reach $220
March 15, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Stocks That Hit 52-Week Lows On Friday
March 12, 2021
During Friday's morning trading, 2 companies set new 52-week lows. Things to Consider: New Oriental Education ...
Tags
Movers
Benzinga
EDU
From
Benzinga
The Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmon's FDA Review, Alzheimer's Data From Prothena
March 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
CEMI
BTAI
SVRA
From
Benzinga
The Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study
March 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
News
OLMA
IMRA
From
Benzinga
Stocks That Hit 52-Week Lows On Thursday
March 04, 2021
Thursday morning, 61 companies reached new 52-week lows. Areas of Significance: The largest company in ...
Tags
XPOA
HKIB
EPZM
From
Benzinga
The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company
March 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
FRLN
INMB
TARA
From
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 03, 2021
During Wednesday's morning session, 8 companies made new 52-week lows. Things to Consider: Viatris ...
Tags
52/Week Lows
Market News
EPZM
From
Benzinga
Epizyme Outlines Clinical Progress, TAZVERIK Development Strategy and Pipeline Priorities During Company’s Strategic Vision Call
March 02, 2021
Epizyme, Inc. (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, hosted a call today outlining the Company’s strategic...
From
Business Wire News Releases
Stocks That Hit 52-Week Lows On Friday
February 26, 2021
During Friday's morning session, 24 stocks hit new 52-week lows. Noteworthy Points: Viatris ...
Tags
DNB
BZI/52Weeks
OPT
From
Benzinga
The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida
February 26, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
MRK
DRNA
ORGO
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 25, 2021
February 25, 2021
Upgrades For Lowe's Companies Inc (NYSE:LOW), Gordon Haskett upgraded the previous rating of Accumulate to Buy. ...
Tags
Intraday Update
PNW
TJX
From
Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 25, 2021
Thursday morning, 1 companyreached new 52-week lows. Epizyme (NASDAQ:EPZM) shares were down 1.86% for ...
Tags
Market News
Movers
52/Week Lows
From
Benzinga
Epizyme to Host Strategic Vision Call on March 2, 2021
February 24, 2021
Epizyme, (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced that it will host a call to discuss the...
From
Business Wire News Releases
Epizyme Inc (EPZM) Q4 2020 Earnings Call Transcript
February 23, 2021
EPZM earnings call for the period ending December 31, 2020.
Tags
Market News
EPZM
From
Motley Fool
CORRECTING and REPLACING Epizyme Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
February 23, 2021
Third subhead of release should read: Safety Run-In Portion of Confirmatory Trials of TAZVERIK® in ES and FL and Phase 1b Portion of Phase 1b/2 Castration-Resistant Prostate Cancer Fully Enrolled;...
From
Business Wire News Releases
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
February 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
MASI
RDHL
CTXR
From
Benzinga
Epizyme: Q4 Earnings Insights
February 23, 2021
Shares of Epizyme (NASDAQ:EPZM) rose 3.4% in pre-market trading after the company reported Q4 results. Quarterly ...
Tags
News
Market News
EPZM
From
Benzinga
Earnings Scheduled For February 23, 2021
February 23, 2021
Companies Reporting Before The Bell • MFA Finl (NYSE:MFA) is likely to report quarterly earnings at $0.07 per share on ...
Tags
HD
EPRT
CLVS
From
Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
February 20, 2021
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ...
Tags
ALIM
ICPT
EDIT
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.